Skip to main content
Top

Cancer and Metastasis Reviews

Issue 3/2017

Content (13 Articles)

Biography—Hidenori Inohara

Hidenori Inohara

Preface

Hidenori Inohara

Tobacco-related carcinogenesis in head and neck cancer

Ashok R. Jethwa, Samir S. Khariwala

Alcohol and head and neck cancer

Daisuke Kawakita, Keitaro Matsuo

Open Access

Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma

Yosuke Nakanishi, Naohiro Wakisaka, Satoru Kondo, Kazuhira Endo, Hisashi Sugimoto, Miyako Hatano, Takayoshi Ueno, Kazuya Ishikawa, Tomokazu Yoshizaki

The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma

Nicholas Fung, Farhoud Faraji, Hyunseok Kang, Carole Fakhry

EGFR-targeted therapies in the post-genomic era

Mary Jue Xu, Daniel E. Johnson, Jennifer R. Grandis

Checkpoint immunotherapy in head and neck cancers

Paul Zolkind, Ravindra Uppaluri

Open Access

mTOR co-targeting strategies for head and neck cancer therapy

Zhiyong Wang, Juan Callejas Valera, Xuefeng Zhao, Qianming Chen, J. Silvio Gutkind

Targeting metabolic pathways for head and neck cancers therapeutics

Masashi Yamamoto, Hidenori Inohara, Takashi Nakagawa

Tumor DNA: an emerging biomarker in head and neck cancer

Joseph A. Bellairs, Rifat Hasina, Nishant Agrawal

Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma

Keiichi Koshizuka, Toyoyuki Hanazawa, Takayuki Arai, Atsushi Okato, Naoko Kikkawa, Naohiko Seki

NON-THEMATIC REVIEW

Breast cancer complexity: implications of intratumoral heterogeneity in clinical management

Brittany Haynes, Ashapurna Sarma, Pratima Nangia-Makker, Malathy P. Shekhar

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine